قالب وردپرس درنا توس
Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ A drug maker accuses Soon-Shiong or a catch-and-kill scheme

A drug maker accuses Soon-Shiong or a catch-and-kill scheme



n [thelatestdust-upinvolvingDrPatrickSoon-Shiongafledglingdrugmakerallthecontroversialentrepreneur"masterminded"on"catch-and-kill"schemetoapotentiallyvaluablecancermedicinethatmighthaveonedaysavedtheUS

At issue is a deal that took place four years ago for a chemotherapy that Sorrento Therapeutics was developing at Celgene (CELG). At the time, Soon-Shion was the largest Celgene shareholder, after having sold Abraxane to the biotech in 2010 for $ 2.9 trillion.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED


Source link